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BY-NC-ND license (http://creativecomBackground/Purpose: Serum anti-gastric parietal cell (GPCA), anti-thyroglobulin (TGA), and
anti-thyroid microsomal antibodies (TMA) can be found in some recurrent aphthous stomatitis
(RAS) patients. This study mainly assessed whether serum GPCA, TGA, TMA and RAS itself
played significant roles in causing anemia and hematinic deficiencies in TGA/TMA-positive
RAS patients with GPCA positivity (GPCAþ/TGA/TMA/RAS patients) or negativity (GPCA
/TGA/TMA/RAS patients).
Methods: The mean corpuscular volume (MCV) and mean blood hemoglobin (Hb), iron, vitamin
B12, and folic acid levels were measured and compared between any two of the four groups of
15 GPCAþ/TGA/TMA/RAS patients, 69 GPCA/TGA/TMA/RAS patients, 240 all autoantibodies-
negative RAS patients (Abs/RAS patients), and 342 healthy control subjects.
Results: GPCAþ/TGA/TMA/RAS patients had significantly lower mean Hb (for men only) and
vitamin B12 levels as well as significantly greater frequencies of Hb, iron, and vitamin B12 de-
ficiencies than healthy control subjects. GPCAþ/TGA/TMA/RAS patients had lower serum
vitamin B12 level and higher MCV as well as a significantly greater frequency of vitamin B12
deficiency than GPCA/TGA/TMA/RAS patients. Furthermore, both GPCA/TGA/TMA/RAS
and Abs/RAS patients did have significantly lower mean Hb, MCV, and iron levels as well asave no conflicts of interest relevant to this article.
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(2016), http://dx.doi.org/10.1016/j.significantly greater frequencies of Hb, iron and vitamin B12 deficiencies than healthy control
subjects. There were no significant differences in blood data between GPCA/TGA/TMA/RAS
and Abs/RAS patients
Conclusion: Both serum GPCA positivity and RAS itself are the contributing factors causing ane-
mia and hematinic deficiencies in GPCAþ/TGA/TMA/RAS patients. RAS itself but not TGA/TMA
positivity plays a significant role in causing anemia and hematinic deficiencies in GPCA/TGA/
TMA/RAS patients.
Copyright ª 2016, Formosan Medical Association. Published by Elsevier Taiwan LLC. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).Introduction
Recurrent aphthous stomatitis (RAS) is a common oral
mucosal disease characterized by recurrent and painful
ulcerations on the movable and nonkeratinized oral
mucosae. The prevalence of RAS is 10.5% in the general
population in Taiwan.1
The exact causes of RAS are still not very clear, although
several etiological factors have been shown to be related to
RAS.2,3 The finding of a mononuclear cell infiltrate in the
subepithelial connective tissue of RAS specimens favor the
role of cell-mediated cytotoxicity in the immunopatho-
genesis of RAS.3 In addition to dysregulation of immune
function, multiple nutritional deficiencies including de-
ficiencies of vitamins B1, B2, B6, and B12, folate, iron, and
ferritin are reported to be the possible etiologies of RAS.3
Our previous studies showed that 57 (20.9%), 55 (20.1%),
13 (4.8%) and 7 (2.6%) of 273 RAS patients have deficiencies
of hemoglobin (Hb), iron, vitamin B12, and folic acid,
respectively.3 We also demonstrated that 13.0%, 19.4%, and
19.7% of 355 RAS patients had the presence of anti-gastric
parietal cell (GPCA), anti-thyroglobulin (TGA), and anti-
thyroid microsomal autoantibodies (TMA) in their sera,
respectively.4 GPCA can induce destruction of gastric pa-
rietal cells, resulting in failure of intrinsic factor produc-
tion.5,6 Intrinsic factor deficiency may cause insufficient
absorption of vitamin B12 that finally leads to the status of
pernicious anemia (PA).7,8 Because multiple factors are
involved in Hb deficiency (anemia) in RAS patients, it is
interesting to know what factors are most important for the
development of anemia or hematinic deficiencies in TGA-
positive and/or TMA-positive (TGA/TMA-positive) RAS pa-
tients with GPCA positivity (GPCAþ/TGA/TMA/RAS pa-
tients) or negativity (GPCA/TGA/TMA/RAS patients).
In our oral mucosal disease clinic, patients with atrophic
glossitis (AG), burning mouth syndrome (BMS), oral lichen
planus (OLP), RAS, oral submucous fibrosis (OSF), and other
oral mucosal diseases are frequently encountered.3,4,9e28
For AG, BMS, OLP, RAS and OSF patients, complete blood
count, serum iron, vitamin B12, folic acid, homocysteine,
anti-nuclear antibody (ANA), anti-smooth muscle antibody
(SMA), anti-mitochondrial antibody (AMA), GPCA, TGA, and
TMA levels were often examined to evaluate whether these
patients have anemia, hematinic deficiencies and serum
ANA, SMA, AMA, GPCA, TGA, or TMA positivity.3,4,9e25 Our
previous studies discovered that 16.1%, 20.2%, 16.1% and
4.0% of 124 GPCA-positive patients (75 AG and 49 BMS pa-
tients), and 16.3%, 14.2%, 6.3% and 1.1% of 190 TGA/TMA-u Y-H, et al., Anemia and hemat
titis patients with anti-thyroid a
jfma.2016.10.008positive patients (83 AG and 107 BMS patients) have Hb,
serum iron, vitamin B12, and folic acid deficiencies,
respectively.14,17 To assess whether the serum GPCA, TGA,
and TMA as well as the disease of RAS itself played signifi-
cant roles in causing anemia and hematinic deficiencies in
GPCAþ/TGA/TMA/RAS patients or GPCA/TGA/TMA/RAS
patients, 15 GPCAþ/TGA/TMA/RAS patients without ANA,
SMA, and AMA positivities, 69 GPCA/TGA/TMA/RAS pa-
tients without ANA, SMA, and AMA positivities, and 240 all
six aforementioned autoantibodies-negative RAS patients
(Abs/RAS patients) were collected and included in this
study. Their complete blood counts as well as serum iron,
vitamin B12, folic acid, and homocysteine levels were
examined and compared with the corresponding data of 342
healthy control subjects. The purposes of this study were to
study the anemia statuses and hematinic deficiencies in
these 15 GPCAþ/TGA/TMA/RAS patients and 69 GPCA/
TGA/TMA/RAS patients and to further clarify the roles of
the serum GPCA, TGA, TMA and/or the disease of RAS itself
in the final development of anemia and hematinic de-
ficiencies in our GPCAþ/TGA/TMA/RAS and GPCA/TGA/
TMA/RAS patients.Materials and methods
Subjects
This study included 84 (18 men and 66 women, age range
26e83 years, mean age 54.5  13.7 years) TGA/TMA/RAS
patients, 240 (78 men and 162 women, age range
18e90 years, mean 50.9  16.3 years) Abs/RAS patients,
and 342 healthy control subjects (104 men and 238 women,
age range 20e89 years, mean 52.7  14.7 years). The 84
TGA/TMA/RAS patients were further divided into 15 (3 men
and 12 women, age range 47e71 years, mean age
61.2  8.0 years) GPCAþ/TGA/TMA/RAS patients and 69 (15
men and 54 women, age range 26e83 years, mean age
53.1  14.3 years) GPCA/TGA/TMA/RAS patients. Patients
were diagnosed as having RAS when they had at least one
episode of oral ulcerations on movable oral mucosa per
month since childhood.3 RAS patients with betel quid
chewing habit or autoimmune diseases (such as systemic
lupus erythematosus, rheumatoid arthritis, Sjogren’s syn-
drome, pemphigus vulgaris, and cicatricial pemphigoid)
were excluded. Moreover, patients with traumatic ulcers or
with aphthous-like ulcers associated with systemic disor-
ders including Behcet’s syndrome, celiac disease, gluten-inic deficiencies in anti-gastric parietal cell antibody-positive and
ntibody positivity, Journal of the Formosan Medical Association
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human immunodeficiency virus infection, and cyclic neu-
tropenia were also excluded.29 In addition, RAS patients
with serum creatinine concentrations indicative of renal
dysfunction (i.e., men, >131 mmol/L; women, >115 mmol/
L), and who reported a history of stroke, heavy alcohol use,
or diseases of the liver, kidney, or coronary arteries were
also excluded.30 Healthy control subjects had either dental
caries, pulpal disease, malocclusion, or missing of teeth but
did not have any oral mucosal or systemic diseases. None of
the RAS patients had taken any prescription medication for
RAS at least 3 months before entering the study.
The blood samples were drawn from all included RAS
patients and healthy control subjects for measurement of
complete blood count, serum iron, vitamin B12, folic acid,
and homocysteine concentrations as well as serum ANA,
SMA, AMA, GPCA, TGA, and TMA levels. All RAS patients and
healthy control subjects signed the informed consents
before entering the study. This study was reviewed and
approved by the Institutional Review Board at the National
Taiwan University Hospital (NTUH).
Determination of complete blood count and serum
iron, vitamin B12, folic acid and homocysteine
concentrations
The complete blood count and serum iron, vitamin B12,
folic acid, and homocysteine concentrations were deter-
mined by the routine tests performed in the Department of
Laboratory Medicine of NTUH as described pre-
viously.3,10,12e16 This study defined the Hb and hematinic
deficiencies according to the World Health Organization
(WHO) criteria. Thus, men with Hb < 13 g/dL and women
with Hb < 12 g/dL were defined as having Hb deficiency or
anemia.20,31 Patients with serum iron level <60 mg/dL,32
vitamin B12 level <200 pg/mL30 or folic acid level <4 ng/
mL33 were defined as having iron, vitamin B12 or folic acid
deficiency, respectively. Moreover, patients with the serum
homocysteine level >12.3 mM (which was the mean serum
homocysteine level of healthy control subjects plus two
standard deviations) were defined as having abnormally
high homocysteine level.
Determination of serum ANA, SMA, AMA, GPCA,
TGA, and TMA levels
The methods of determination of serum ANA, SMA, AMA,
GPCA, TGA, and TMA levels in our RAS patients and healthy
control subjects have been described in our previous
studies.4,9e14,17
Statistical analysis
Comparisons of the mean MCV and mean blood levels of Hb,
iron, vitamin B12, folic acid and homocysteine between any
two of the four groups of GPCAþ/TGA/TMA/RAS patients,
GPCA/TGA/TMA/RAS patients, Abs/RAS patients, and
healthy control subjects were performed by Student’s t-
test. The differences in frequency of Hb, iron, vitamin B12
or folic acid deficiency, or frequency of abnormally high
blood homocysteine level between any two of the fourPlease cite this article in press as: Wu Y-H, et al., Anemia and hemat
-negative recurrent aphthous stomatitis patients with anti-thyroid a
(2016), http://dx.doi.org/10.1016/j.jfma.2016.10.008groups of GPCAþ/TGA/TMA/RAS patients, GPCA/TGA/
TMA/RAS patients, Abs/RAS patients, and healthy control
subjects were compared by chi-square test. Comparisons of
mean MCV and mean blood concentrations of Hb, iron,
vitamin B12, folic acid and homocysteine between any two
of the three groups of patients with macrocytic, normocytic
or microcytic RBCs were performed by Student’s t-test. The
result was considered to be significant if the P-value was
less than 0.05.Results
The mean MCV and mean blood concentrations of Hb, iron,
vitamin B12, folic acid, and homocysteine in 15 GPCAþ/
TGA/TMA/RAS patients, 69 GPCA/TGA/TMA/RAS patients,
240 Abs/RAS patients, and 342 healthy control subjects
are shown in Table 1. Because men usually had higher blood
levels of Hb and iron than women, these two mean levels
were calculated separately for men and women. We found
significantly lower mean Hb (for men only, P < 0.001) and
vitamin B12 (P < 0.001) levels as well as significantly higher
mean blood homocysteine level (P < 0.001) in GPCAþ/TGA/
TMA/RAS patients than in healthy control subjects (Table
1). Moreover, we found a lower mean vitamin B12 level
(P Z 0.062, marginal significance), a higher mean MCV
(P Z 0.059, marginal significance), and a significantly
higher mean blood homocysteine level (P < 0.001) in
GPCAþ/TGA/TMA/RAS patients than in GPCA/TGA/TMA/
RAS patients. In addition, GPCA/TGA/TMA/RAS patients
had a significantly lower mean Hb (for men and women,
both P-values < 0.001), lower mean MCV (P < 0.001), and
lower mean iron (for men. P Z 0.018; for women,
P < 0.001) than healthy control subjects. GPCA/TGA/
TMA/RAS patients had a significantly higher mean Hb (for
women only, both P Z 0.022) than Abs/RAS patients.
However, there were no significant differences in MCV and
blood Hb (for men only), iron, vitamin B12, folic acid and
homocysteine levels between GPCA/TGA/TMA/RAS pa-
tients and Abs/RAS patients. Furthermore, Abs/RAS
patients had significantly lower mean Hb (for men and
women, both P-values < 0.001), MCV (P < 0.001), iron (for
men and women, both P-values < 0.001), vitamin B12
(P Z 0.072, marginal significance), and folic acid levels
(P Z 0.005) than healthy control subjects (Table 1).
We also found significantly greater frequencies of Hb,
iron and vitamin B12 deficiencies in GPCAþ/TGA/TMA/RAS,
GPCA/TGA/TMA/RAS, and Abs/RAS patients as well as
significantly greater frequencies of high blood homocyste-
ine level in GPCAþ/TGA/TMA/RAS and Abs/RAS patients
than in healthy control subjects (all P-values < 0.001)
(Table 2). There were also significantly greater frequencies
of vitamin B12 deficiency (P Z 0.014) and of high serum
homocysteine level (P Z 0.001) in GPCAþ/TGA/TMA/RAS
patients than in GPCA/TGA/TMA/RAS patients. However,
there were no significant differences in frequencies of
blood Hb, iron, vitamin B12, folic acid deficiencies and of
high serum homocysteine level between GPCA/TGA/TMA/
RAS patients and Abs/RAS patients.
In this study, 3 (20.0%) of 15 GPCAþ/TGA/TMA/RAS pa-
tients and 14 (20.3%) of 69 GPCA/TGA/TMA/RAS patients
were diagnosed as having anemia according to the WHOinic deficiencies in anti-gastric parietal cell antibody-positive and
ntibody positivity, Journal of the Formosan Medical Association
Table 1 Comparisons of the mean corpuscular volume (MCV) and mean blood concentrations of hemoglobin (Hb), iron, vitamin
B12, folic acid and homocysteine between any two of the four groups of 15 anti-thyroglobulin antibody (TGA)-positive and/or
anti-thyroid microsomal antibody (TMA)-positive recurrent aphthous stomatitis (RAS) patients (TGA/TMA/RAS patients) with
anti-gastric parietal cell antibody (GPCA)-positivity (GPCAþ/TGA/TMA/RAS patients), 69 GPCA-negative TGA/TMA/RAS patients
(GPCA/TGA/TMA/RAS patients), 240 all autoantibodies-negative RAS patients (Abs/RAS patients), and 342 healthy control
subjects.
Group Hb (g/dL) MCV (fl) Iron (mg/dL) Vitamin B12
(pg/mL)
Folic acid
(ng/mL)
Homocysteine
(mM)Men Women Men Women
GPCAþ/
TGA/TMA/
RAS patients
(n Z 15)
13.0  0.7
(n Z 3)
13.6  1.1
(n Z 12)
91.4  4.0 107.3  69.3
(n Z 3)
85.2  30.8
(n Z 12)
472.9  278.0 16.2  7.4 19.7  22.7
aP-value <0.001 >0.999 0.475 0.864 0.105 0.001 0.183 <0.001
bP-value 0.754 0.143 0.059 0.394 0.527 0.062 0.094 <0.001
GPCA/TGA/
TMA/RAS
patients
(n Z 69)
13.4  2.1
(n Z 15)
13.0  1.3
(n Z 54)
86.4  9.9 85.9  31.2
(n Z 15)
79.1  29.9
(n Z 54)
621.8  276.4 13.1  6.2 8.4  5.5
aP-value <0.001 <0.001 <0.001 0.018 <0.001 0.092 0.204 0.789
cP-value 0.163 0.022 0.493 0.768 0.670 0.653 0.588 0.765
Abs/RAS
patients
(n Z 240)
14.1  1.7
(n Z 78)
12.5  1.4
(n Z 162)
87.2  8.1 88.8  35.4
(n Z 78)
81.4  35.6
(n Z 162)
638.4  268.6 12.6  6.9 8.7  7.8
aP-value <0.001 <0.001 <0.001 <0.001 <0.001 0.072 0.005 0.649
Healthy control
subjects
(n Z 342)
15.2  0.7
(n Z 104)
13.6  0.7
(n Z 238)
90.7  3.7 104.4  27.4
(n Z 104)
98.8  28.1
(n Z 238)
676.5  238.6 14.1  5.9 8.5  1.9
a Comparisons of parameters between 15 GPCAþ/TGA/TMA/RAS patients, 69 GPCA/TGA/TMA/RAS patients, or 240 Abs/RAS pa-
tients and 218 healthy control subjects.
b Comparisons of parameters between 15 GPCAþ/TGA/TMA/RAS patients and 69 GPCA/TGA/TMA/RAS patients.
c Comparisons of parameters between 69 GPCA/TGA/TMA/RAS patients and 240 Abs/RAS patients.
Table 2 Comparisons of frequencies of hemoglobin (Hb), iron, vitamin B12, and folic acid deficiencies and frequency of
abnormally high blood homocysteine level between any two of the four groups of 15 anti-thyroglobulin antibody (TGA)-positive
and/or anti-thyroid microsomal antibody (TMA)-positive recurrent aphthous stomatitis (RAS) patients (TGA/TMA/RAS patients)
with anti-gastric parietal cell antibody (GPCA)-positivity (GPCAþ/TGA/TMA/RAS patients), 69 GPCA-negative TGA/TMA/RAS
patients (GPCA/TGA/TMA/RAS patients), 240 all autoantibodies-negative RAS patients (Abs/RAS patients), and 342 healthy
control subjects.
Group Hb deficiency
(Men < 13 g/dL,
Women < 12 g/dL)
Iron deficiency
(<60 mg/dL)
Vitamin B12 deficiency
(<200 pg/mL)
Folic acid
deficiency
(<4 ng/mL)
High homocysteine
level (>12.3 mM)
GPCAþ/TGA/TMA/
RAS patients (n Z 15)
3 (20.0%) 3 (20.0%) 5 (33.3%) 0 (0.0%) 6 (40.0%)
aP-value <0.001 <0.001 <0.001 ND <0.001
bP-value >0.999 0.750 0.014 ND 0.001
GPCA/TGA/TMA/
RAS patients (n Z 69)
14 (20.3%) 20 (29.0%) 5 (7.2%) 0 (0.0%) 3 (4.3%)
aP-value <0.001 <0.001 <0.001 ND 0.100
cP-value 0.081 0.982 0.918 0.123 0.221
Abs/RAS patients (n Z 240) 77 (32.1%) 67 (27.9) 16 (6.7%) 12 (5%) 24 (10%)
aP-value <0.001 <0.001 <0.001 <0.001 <0.001
Healthy control
subjects (n Z 342)
0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 3 (0.9%)
a Comparisons of parameters between 15 GPCAþ/TGA/TMA/RAS patients, 69 GPCA/TGA/TMA/RAS patients, or 240 Abs/RAS pa-
tients and 218 healthy control subjects.
b Comparisons of parameters between 15 GPCAþ/TGA/TMA/RAS patients and 69 GPCA/TGA/TMA/RAS patients.
c Comparisons of parameters between 69 GPCA/TGA/TMA/RAS patients and 240 Abs/RAS patients.
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Table 3 Anemia types of 17 anti-thyroglobulin antibody (TGA)-positive and/or anti-thyroid microsomal antibody (TMA)-pos-
itive recurrent aphthous stomatitis (RAS) patients (TGA/TMA/RAS patients), of 3 anti-gastric parietal cell antibody-positive
TGA/TMA/RAS patients (GPCAþ/TGA/TMA/RAS patients), and of 14 GPCA-negative TGA/TMA/RAS patients (GPCA/TGA/
TMA/RAS patients).
Anemia type Patient number (%)
Patient number (%) MCV Vitamin B12 deficiency
(<200 pg/mL)
Iron deficiency (<60 mg/dL)
TGA/TMA/RAS patients (n [ 84)
Pernicious anemia 2 (11.8) S 100 fl 2 (100.0) 1 (50.0)
Macrocytic anemia 2 (11.8) S 100 fl 2 (100.0) 0 (0.0)
Normocytic anemia 5 (29.4) 80e99.9 fl 1 (20.0) 4 (80.0)
Iron deficiency anemia 5 (29.4) <80 fl 0 (0.0) 5 (100.0)
Thalassemia trait 3 (17.6) <74 fl 0 (0.0) 0 (0.0)
Total 17 (100.0) 5 (29.4) 10 (58.8)
GPCAD/TGA/TMA/RAS patients (n [ 15)
Pernicious anemia 2 (66.7) S 100 fl 2 (100.0) 1 (50.0)
Normocytic anemia 1 (33.3) 80e99.9 fl 1 (100.0) 1 (100.0)
Total 3 (100.0) 3 (100.0) 2 (66.7)
GPCA/TGA/TMA/RAS patients (n [ 69)
Macrocytic anemia 2 (14.3) S 100 fl 2 (100.0) 0 (0.0)
Normocytic anemia 4 (28.6) 80e99.9 fl 0 (0.0) 3 (75.0)
Iron deficiency anemia 5 (35.7) <80 fl 0 (0.0) 5 (100.0)
Thalassemia trait 3 (21.4) <74 fl 0 (0.0) 0 (0.0)
Total 14 (100.0) 2 (14.3) 8 (57.1)
Table 4 The mean corpuscular volume (MCV) and mean blood concentrations of hemoglobin (Hb), iron, vitamin B12, folic
acid, and homocysteine, in 15 anti-gastric parietal cell antibody (GPCA)-positive and anti-thyroglobulin antibody (TGA)/anti-
thyroid microsomal antibody (TMA)-positive recurrent aphthous stomatitis (RAS) patients (GPCAþ/TGA/TMA/RAS patients)
including 2 with MCV S 100 fl (group 1) and 13 with MCV between 80 fl and 99.9 fl (group 2).
GPCAþ/TGA/TMA/RAS patients (n Z 15)
Group 1 MCV S 100 fl (n Z 2) P-value* (Group 1 vs. 2) Group 2 MCV 80e99.9 fl (n Z 13)
Mean  SD Mean  SD
Hb (g/dL)
Men 12.5  0.1 (n Z 2) 0.296 13.3  0.8 (n Z 2)
Women (n Z 0) ND 13.7  1.1 (n Z 11)
MCV (fl) 100.3  0.3 <0.001 90.0  1.9
Iron (mg/dL)
Men 117.0  93.3 (n Z 2) 0.566 69.5  31.8 (n Z 2)
Women (n Z 0) ND 88.3  30.2 (n Z 11)
Vitamin B12 (pg/mL) 150.0  0.0 0.076 522.6  264.8
Folic acid (ng/mL) 24.0  0.0 0.110 15.0  7.2
Homocysteine (mM) 61.2  23.1 0.001 13.3  14.9
*Comparisons of MCV and mean blood concentrations of Hb, iron, vitamin B12, folic acid and homocysteine between groups 1 and 2 by
Student’s t-test.
ND Z not done.
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+ MODELcriteria (Table 3).31 The different anemia types of 3 anemic
GPCAþ/TGA/TMA/RAS patients and of 14 anemic GPCA/
TGA/TMA/RAS patients are described in detail in Table 3. In
this study, PA was diagnosed as having MCV S 100 fl,
vitamin B12 < 200 pg/mL, and serum GPCA positivity,17e19
iron deficiency anemia as having MCV <80 fl and iron
<60 mg/dL20,31,32; and thalassemia trait as having MCV
<74 fl, RBC count >5.0  1012/L, and Mentzer index (MCV/
RBC) < 13.23 By these definitions, of 3 anemic GPCAþ/TGA/Please cite this article in press as: Wu Y-H, et al., Anemia and hemat
-negative recurrent aphthous stomatitis patients with anti-thyroid a
(2016), http://dx.doi.org/10.1016/j.jfma.2016.10.008TMA/RAS patients, 2 had PA and one had normocytic ane-
mia. Moreover, of 14 anemic GPCA/TGA/TMA/RAS pa-
tients, 2 had macrocytic anemia but not PA, 4 had
normocytic anemia, 5 had iron deficiency anemia, 3 had
thalassemia trait.
When 15 GPCAþ/TGA/TMA/RAS patients were further
divided into two groups: group 1 (2 patients with
MCV S 100 fl) and group 2 (13 patients with MCV between
80 fl and 99.9 fl), we found that group 1 patients hadinic deficiencies in anti-gastric parietal cell antibody-positive and
ntibody positivity, Journal of the Formosan Medical Association
Table 5 The mean corpuscular volume (MCV) and mean blood concentrations of hemoglobin (Hb), iron, vitamin B12, folic
acid, and homocysteine, in 69 anti-gastric parietal cell antibody (GPCA)-negative and anti-thyroglobulin antibody (TGA)/anti-
thyroid microsomal antibody (TMA)-positive recurrent aphthous stomatitis (RAS) patients (GPCA/TGA/TMA/RAS patients)
including 2 with MCV S 100 fl (group 1), 53 with MCV between 80 fl and 99.9 fl (group 2), and 14 with MCV < 80 fl (group 3).
GPCA/TGA/TMA/RAS patients (n Z 69)
Group 1
MCV
S 100 fl
(n Z 2)
P-value*
(Group 1 vs. 2)
Group 2 MCV
80e99.9 fl
(n Z 53)
P-value*
(Group 2 vs. 3)
Group 3 MCV
<80 fl
(n Z 14)
P-value*
(Group 1
vs. 3)
Mean  SD Mean  SD Mean  SD
Hb (g/dL)
Men 10.9 (n Z 1) ND 13.6  2.2 (n Z 13) ND 13.2 (n Z 1) ND
Women 11.6 (n Z 1) ND 13.5  0.9 (n Z 40) <0.001 11.6  1.3 (n Z 13) ND
MCV (fl) 103.6  4.1 <0.001 90.1  4.1 <0.001 70.1  7.4 <0.001
Iron (mg/dL)
Men 19.9 (n Z 1) ND 83.5  32.6 (n Z 13) ND 89 (n Z 1) ND
Women 43.3 (n Z 1) ND 85.6  27.1 (n Z 40) 0.008 60.6  32.0 (n Z 13) ND
Vitamin
B12 (pg/mL)
150.0  0.0 0.017 632.2  274.8 0.830 649.7  248.8 0.015
Folic acid
(ng/mL)
16.6  10.5 0.484 13.2  6.6 0.630 12.3  4.2 0.267
Homocysteine
(mM)
31.6  16.6 <0.001 7.9  3.3 0.238 6.8  1.9 <0.001
*Comparisons of MCV and mean blood concentrations of Hb, iron, vitamin B12, folic acid and homocysteine between groups 1 and 2,
between groups 2 and 3, and between groups 1 and 3 by Student’s t-test.
ND Z not done.
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+ MODELsignificantly higher MCV (P < 0.001), lower mean serum
vitamin B12 level (P Z 0.076, marginal significance), and
significantly higher mean serum homocysteine level
(P Z 0.001) than group 2 patients (Table 4). None of 15
GPCAþ/TGA/TMA/RAS patients had their MCV <80 fl (Table
4).
We also divided 69 GPCA/TGA/TMA/RAS patients into
three groups: group 1 (2 patients with MCVS 100 fl), group
2 (53 patients with MCV between 80 fl and 99.9 fl), and
group 3 (14 patients with MCV < 80 fl). We found that group
1 patients had significantly higher MCV (P < 0.001), lower
mean serum vitamin B12 level (P Z 0.017), and higher
mean serum homocysteine level (P < 0.001) than group 2
patients (Table 5). Group 3 patients had significantly lower
mean Hb level (for women only, P < 0.001), lower MCV
(P < 0.001), and lower mean serum iron level (for women
only, PZ 0.008) than group 2 patients (Table 5). Moreover,
group 1 had significantly higher MCV (P < 0.001), lower
mean serum vitamin B12 level (P Z 0.015), and higher
mean serum homocysteine level (P < 0.001) than group 3
patients (Table 5).Discussion
This study found that GPCAþ/TGA/TMA/RAS patients had
significantly lower mean Hb (for men only) and serum
vitamin B12 levels as well as significantly higher mean
serum homocysteine level than healthy control subjects.
Moreover, GPCAþ/TGA/TMA/RAS patients had significantly
greater frequencies of Hb, serum iron, and serum vitamin
B12 deficiencies and of high serum homocysteine level thanPlease cite this article in press as: Wu Y-H, et al., Anemia and hemat
-negative recurrent aphthous stomatitis patients with anti-thyroid a
(2016), http://dx.doi.org/10.1016/j.jfma.2016.10.008healthy control subjects. These two findings suggest that
the anemia status and hematinic deficiencies in GPCAþ/
TGA/TMA/RAS patients may be attributed to serum GPCA
positivity, TGA/TMA positivity, and/or the disease of RAS
itself. To elucidate these equivocal probabilities, we
compared the blood data between 15 GPCAþ/TGA/TMA/
RAS patients and 69 GPCA/TGA/TMA/RAS patients. We
found GPCAþ/TGA/TMA/RAS patients had lower serum
vitamin B12 level, higher MCV, and significantly higher
serum homocysteine level as well as significantly greater
frequencies of vitamin B12 deficiency and of high serum
homocysteine level than GPCA/TGA/TMA/RAS patients.
These findings indicate that the serum GPCA positivity play
an important role in causing vitamin B12 deficiency, high
MCV, and high homocysteine level in GPCAþ/TGA/TMA/RAS
patients. Furthermore, this study also found that both
GPCA/TGA/TMA/RAS and Abs/RAS patients did have
significantly lower mean Hb, MCV, and serum iron levels as
well as significantly greater frequencies of Hb, iron and
vitamin B12 deficiencies than healthy control subjects.
Female GPCA/TGA/TMA/RAS patients had significantly
higher mean Hb level than female Abs/RAS patients.
However, there were no significant differences in MCV and
mean blood Hb (for men only), iron, vitamin B12, and folic
acid, and homocysteine levels as well as in frequencies of
blood Hb, iron, vitamin B12, and folic acid deficiencies and
of high serum homocysteine level between GPCA/TGA/
TMA/RAS patients and Abs/RAS patients These findings
indicate TGA/TMA positivity does not play a significant role
in causing anemia and hematinic deficiencies in GPCA/
TGA/TMA/RAS patients. We also found that Abs/RAS pa-
tients did have significantly lower MCV and lower meaninic deficiencies in anti-gastric parietal cell antibody-positive and
ntibody positivity, Journal of the Formosan Medical Association
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significantly greater frequencies of Hb, iron, vitamin B12,
and folic acid deficiencies and of high serum homocysteine
level than healthy control subjects. These findings indicate
that the disease of RAS itself does play a significant role in
causing anemia and hematinic deficiencies in GPCA/TGA/
TMA/RAS patients and Abs/RAS patients.
The serum GPCA can induce destruction of gastric pari-
etal cells, resulting in failure of intrinsic factor produc-
tion.5,6 Complete or partial loss of intrinsic factor causes
vitamin B12 deficiency that finally leads to macrocytosis
and the status of PA.7,8 Vitamin B12 and folic acid de-
ficiencies can lead to high serum homocysteine level in oral
mucosal disease patients.3,10,14e16 However, supplementa-
tion of multiple B vitamins especially vitamin B12 and folic
acid can reduce the serum homocysteine levels in patients
with AG or BMS.24,34 Therefore, the higher frequency of
vitamin B12 deficiency, higher MCV, and higher homocys-
teine level in GPCAþ/TGA/TMA/RAS patients than in
healthy control patients are predominantly due to the
presence of GPCA in GPCAþ/TGA/TMA/RAS patients’ sera.
Vitamin B12 deficiency can result in a significantly reduced
production of Hb.18 Moreover, deficiency of vitamin B12
inhibits purine and thymidylate syntheses, impairs DNA
synthesis, and causes erythroblast apoptosis, leading to
anemia from ineffective erythropoiesis.35 Therefore, GPCA-
induced vitamin B12 deficiency can at least partially
explain why some of our GPCAþ/TGA/TMA/RAS patients
have low Hb level and anemia.
We further explain why RAS itself may be an important
factor causing anemia and hematinic deficiencies in RAS
patients. A previous diet history questionnaire study
showed a significantly lower daily intake of vitamin B12 and
folate in minor-typed RAS patients than in control sub-
jects.36 This finding suggests that the frequent presence of
single or multiple small oral ulcerations may result in a
significantly lower daily intake of vitamin B12 and folate. By
definition, the major-typed RAS patients often have severer
and larger recurrent oral ulcerations than minor-typed RAS
patients.3 These severer ulcerative lesions may cause
burning sensation and pain of the lesional oral mucosae
when the patients eat salty and spicy food stuffs. The
eating difficulty may lead to reduced food intake that in
turn causes anemia and hematinic deficiencies in a certain
percentage of our TGA/TMA/RAS patients.
In this study, 3 (20.0%) of the 15 GPCAþ/TGA/TMA/RAS
patients and 14 (20.3%) of 69 GPCA/TGA/TMA/RAS pa-
tients had anemia.20,31 Five types of anemia including
pernicious, macrocytic, normocytic, or iron deficiency
anemia and thalassemia trait were detected in our TGA/
TMA/RAS patients (Table 3). We also found that 2 of 2 PA
patients (one patient had concomitant iron deficiency) and
2 of 2 macrocytic anemia patients had vitamin B12 but not
folic acid deficiency, suggesting that these two types of
anemia are predominantly due to vitamin B12 deficiency.
Of 5 normocytic anemia patients, 4 (80.0%) had iron defi-
ciency and one (20.0%) had vitamin B12 deficiency, indi-
cating that normocytic anemia in our TGA/TMA/RAS
patients are predominantly due to iron deficiency and
secondarily due to vitamin B12 deficiency. In our 5 iron
deficiency anemia patients, none had concomitant vitamin
B12 and folic acid deficiencies. Furthermore, none of our 3Please cite this article in press as: Wu Y-H, et al., Anemia and hemat
-negative recurrent aphthous stomatitis patients with anti-thyroid a
(2016), http://dx.doi.org/10.1016/j.jfma.2016.10.008thalassemia trait patients had vitamin B12, iron or folic acid
deficiency, indicating the Hb deficiency in thalassemia trait
patients is merely due to gene mutation resulting in insuf-
ficient production of either the a-globin or b-globin chains
of the Hb molecule.23
Of the 15 GPCAþ/TGA/TMA/RAS patients, 2 (13.3%,
group 1 patients) produced macrocytic RBCs and 13 (86.7%,
group 2 patients) normocytic RBCs. We also found that 2
(40.0%) of 5 vitamin B12-deficient GPCAþ/TGA/TMA/RAS
patients and 2 (100.0%) of 2 macrocytosis GPCAþ/TGA/
TMA/RAS patients had PA. Only one of 13 normocytosis
GPCAþ/TGA/TMA/RAS patients had normocytic anemia. Of
the 69 GPCA/TGA/TMA/RAS patients, 2 (2.9%, group 1
patients) produced macrocytic RBCs, 53 (76.8%, group 2
patients) normocytic RBCs, and 14 (20.3%, group 3 patients)
microcytic RBCs. Compared to group 2 patients, both
groups 1 and 3 patients had relatively severe anemia, group
3 patients tended to have relatively low serum iron level
(for women only), group 1 patients usually had low serum
vitamin B12 level and significantly high blood homocysteine
level, and group 3 patients usually had no vitamin B12 and
folic acid deficiencies. These findings also prove the inti-
mate association of vitamin B12 deficiency with macrocy-
tosis and abnormally high serum homocysteine level as well
as the close relation between iron deficiency and micro-
cytosis in our TGA/TMA/RAS patients.
We conclude that both serum GPCA positivity and RAS
itself are the contributing factors causing anemia and he-
matinic deficiencies in GPCAþ/TGA/TMA/RAS patients.
Serum GPCA is the major factor causing vitamin B12 defi-
ciency, macrocytosis and pernicious anemia in GPCAþ/
TGA/TMA/RAS patients. TGA/TMA positivity does not play a
significant role causing anemia and hematinic deficiencies
in both GPCAþ/TGA/TMA/RAS and GPCA/TGA/TMA/RAS
patients. RAS itself does play a significant role in causing
anemia and hematinic deficiencies in GPCA/TGA/TMA/
RAS and Abs/RAS patients.Acknowledgements
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